Robeco Institutional Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $527M | Sell |
|
|||||
2025
Q1 | $580M | Sell |
|
|||||
2024
Q4 | $599M | Sell |
|
|||||
2024
Q3 | $733M | Buy |
|
|||||
2024
Q2 | $654M | Sell |
|
|||||
2024
Q1 | $607M | Buy |
|
|||||
2023
Q4 | $390M | Sell |
|
|||||
2023
Q3 | $444M | Sell |
|
|||||
2023
Q2 | $474M | Buy |
|
|||||
2023
Q1 | $308M | Sell |
|
|||||
2022
Q4 | $404M | Sell |
|
|||||
2022
Q3 | $462M | Buy |
|
|||||
2022
Q2 | $449M | Sell |
|
|||||
2022
Q1 | $424M | Sell |
|
|||||
2021
Q4 | $428M | Sell |
|
|||||
2021
Q3 | $440M | Sell |
|
|||||
2021
Q2 | $464M | Sell |
|
|||||
2021
Q1 | $396M | Sell |
|
|||||
2020
Q4 | $447M | Sell |
|
|||||
2020
Q3 | $394M | Buy |
|
|||||
2020
Q2 | $425M | Buy |
|
|||||
2020
Q1 | $223M | Buy |
|
|||||
2019
Q4 | $205M | Buy |
|
|||||
2019
Q3 | $138M | Buy |
|
|||||
2019
Q2 | $114M | Buy |
|
|||||
2019
Q1 | $104M | Buy |
|
|||||
2018
Q4 | $74.5M | Buy |
|
|||||
2018
Q3 | $54.6M | Buy |
|
|||||
2018
Q2 | $37.4M | Sell |
|
|||||
2018
Q1 | $36.1M | Buy |
|
|||||
2017
Q4 | $33.6M | Buy |
|
|||||
2017
Q3 | $19.7M | Buy |
|
|||||
2017
Q2 | $19M | Buy |
|
|||||
2017
Q1 | $16.9M | Buy |
|
|||||
2016
Q4 | $10.9M | Sell |
|
|||||
2016
Q3 | $89.2M | Buy |
|
|||||
2016
Q2 | $87.3M | Sell |
|
|||||
2016
Q1 | $81.8M | Sell |
|
|||||
2015
Q4 | $96.7M | Buy |
|
|||||
2015
Q3 | $78.9M | Buy |
|
|||||
2015
Q2 | $78.4M | Sell |
|
|||||
2015
Q1 | $72.1M | Sell |
|
|||||
2014
Q4 | $69.8M | Buy |
|
|||||
2014
Q3 | $59.2M | Buy |
|
|||||
2014
Q2 | $50.9M | Buy |
|
|||||
2014
Q1 | $45M | Buy |
|
|||||
2013
Q4 | $32.3M | Buy |
|
|||||
2013
Q3 | $31.6M | Buy |
|
|||||
2013
Q2 | $29.8M | Buy |
|